Ulcers Clinical Trial
Verified date | September 2019 |
Source | Henry Ford Health System |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To determine if a device that measures and displays pressure that the patients feel when in bed can help nurses reposition the patient effectively and thereby reduce bedsores in the intensive care unit.
Status | Completed |
Enrollment | 428 |
Est. completion date | September 2012 |
Est. primary completion date | October 2011 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - 18 years and older, - care giver trained on mapping system Exclusion Criteria: - Less than 18 years, - pregnant women, - weight greater 550 lbs, and subjects requiring a specialty mattress |
Country | Name | City | State |
---|---|---|---|
United States | Henry Ford Hospital | Detroit | Michigan |
Lead Sponsor | Collaborator |
---|---|
Henry Ford Health System | Wellsense USA Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pressure Mapping Reducing Hospital Acquired Pressure Ulcers | Comparing number of pressure ulcers when using pressure mapping compared to when not. | Time admitted in the Medical Intensive Care Unit |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01214811 -
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
|
Phase 3 | |
Terminated |
NCT00700154 -
Insulin Infusion Diabetes Ulcer
|
N/A | |
Completed |
NCT01138436 -
A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers
|
Phase 2 | |
Completed |
NCT01548378 -
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
|
Phase 2 | |
Completed |
NCT01942941 -
Peripheral Vascular Disease and Nerve Stimulation
|
N/A | |
Completed |
NCT00718978 -
Clinical Application of Autologous Three-Cellular Cultured Skin Substitutes (CSS)
|
N/A | |
Completed |
NCT00951080 -
SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
|
N/A | |
Suspended |
NCT00701974 -
Non-inferiority Clinic of Kollagenase® Compared Iruxol® in Treatment of Cutaneous Ulcers
|
Phase 2/Phase 3 | |
Terminated |
NCT01474122 -
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
|
Phase 3 | |
Completed |
NCT01474109 -
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
|
Phase 3 | |
Completed |
NCT00597818 -
Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury
|
Phase 2 | |
Completed |
NCT00189540 -
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
|
Phase 2 | |
Recruiting |
NCT04275323 -
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1)
|
Phase 3 | |
Completed |
NCT04274049 -
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2)
|
Phase 3 | |
Completed |
NCT00688428 -
Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination
|
Phase 1 |